CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Phase I-II Study of Dose Dense PEG-Filgrastim and GM-CSF as Support for Dose Dense CHOP-R Front Line Therapy for Aggressive Non-Hodgkin's Lymphoma (NHL).
Author
Ezequiel Rivera
Fernando Cabanillas
+4Â more
Idalia Liboy
Margarita Bruno
Maribel Cotto
Orestes A. Pavia
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
A Phase II Study of Gemcitabine, Rituximab, and Oxaliplatin In Combination for Relapsed/Refractory Non-Hodgkin's Lymphomas
Author
Celeste M. Bello
Eduardo M. Sotomayor
+6Â more
Enrique Santana
Fernando Cabanillas
Idalia Liboy
Jennifer L. Cultrera
Jijun Liu
Lubomir Sokol
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
No full text
No full text
